A Win For Kala Pharmaceuticals, Inc.

Fri, Dec 30, 2022 at 07:06 PM
A Win For Kala Pharmaceuticals, Inc.

Kala Pharmaceuticals, Inc. (KALA:NASDAQ) soared at $38.15, representing a gain of 53.6%. On Fri, Dec 30, 2022, KALA:NASDAQ hit a New 2-Week High of $38.15. The stock got featured on our News Catalysts scanner on Fri, Dec 30, 2022 at 02:14 PM in the 'BIOTECH' category. From Fri, Dec 16, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days

About Kala Pharmaceuticals, Inc. (KALA:NASDAQ)

Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.